Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Thromb Res. 2021 Nov 27;209:99–104. doi: 10.1016/j.thromres.2021.11.018

Table 1.

baseline characteristics of patients’ cohort

Variable Early Group
(n=88)
Delayed Group
(n=49)
P value
Age (mean ±SD) 67.18(±14.17) 64.42(±10.7) 0.28
Male (n, %) 51 (58%) 25 (51%) 0.43
Hypertension (n, %) 39 (44%) 19 (38%) 0.52
Diabetes (n, %), 22 13 0.84
NIHSS Score, Median(IQR) 17(10.5–23) 17.5 (7.25–21.5) 0.39
Premedication with Anti-platelets (n, %) 52 (59%) 26 (53%) 0.49
Premedication with Anti-coagulant (n,%) 6 (%7) 4 (%8) 0.77
Occlusion Site (n, %)
ICA 16 (18%) 13(26%)
ICA Terminus 13 (15%) 7 (14%)
M1 42 (48%) 21 (43%)
M2 22 (25%) 13 (27%)
A1 4 (5%) 0 (0%)
Vertebral 1 (1%) 1(2%)
Basilar 4 (5%) 3(6%)
P1 3 (3%) 1 (2%) 0.36
IV-tPA (n, %)
Yes 42 (48%) 25 (51%)
No 46 (52%) 24 (49%) 0.62
Etiology (n, %)
Large Artery atherosclerosis (LAA) 46(52%) 18 (37%)
Cardioembolic 11(13%) 14 (29%)
Unknown 15 (17%) 5 (10%)
Other 16 (18%) 12 (24%) 0.06
Final TICI Score 2b-3 (n,%) 84 (95%) 47 (96%) 0.48
Number of passes required (Median) 2.09 (±1.67) 2.49 (±1.83) 0.24
Time to recanalization (minutes) 24.32(±14.83) 32.23 (±35.59) 0.18
Thrombectomy technique (n, %)
Aspiration 54 (61%) 35 (71%)
Stent retriever 8 (9%) 3 (6%)
Combination 26 (30%) 11 (22%) 0.49